PTC Therapeutics | PTCT - Capitale Ordinario

Prezzo Delle Azioni
68.23
Cambio Giornaliero
-0.36 -0.52%
Mensile
2.22%
Annuale
37.75%
Q2 Previsione
66.77




Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Amgen USD 539M 1000K 2025-12
BioCryst Pharmaceuticals USD 213.06M 2.54M 2025-12
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.3M 201K 2025-12
Cytokinetics USD 122.26M 145K 2025-12
Daiichi Sankyo JPY 1.85B 9K 2025-12
Enanta Pharmaceuticals USD 212K 1000 2023-12
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
Incyte USD 198.46M 2.33M 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.69B 1000K 2025-09
PTC Therapeutics USD 81.47M 1.54M 2025-12
Puma Biotechnology USD 5K 0 2024-06
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.96M 196K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vertex Pharmaceuticals USD 254M 0 2025-12
Xencor USD 71.87M 529K 2025-12